3H3-49382-81990
4 vaccinations
6 coded responses
53 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 207 / MD
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
- 2021-03-28
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-06-30
Survey response — 3 months, dose 2MedDRA: Fatigue, Office visit — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Extreme tiredness · Healthcare visit (other): Primary care physicianMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-30
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-03
-
2021-09-29
Survey response — 6 months, dose 2MedDRA: Arthritis, Cheilitis, Eye inflammation, Inflammation, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Systemic inflammation, especially joints, eyes, lips · Healthcare visit (other): PCP and specialists in-officeMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-02
-
2021-10-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-13
Dose 3 — Pfizer-BioNTech
- 2022-01-13
- 2022-01-14
- 2022-01-15
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-27
-
2022-02-03
Survey response — day 21, dose 3MedDRA: Arthralgia, Pre-existing disease, Rheumatoid arthritis — Feeling: FairFree text: Having rheumatoid arthritis (RA) , I had stopped methotrexate (MTX) for 2 weeks after getting 3rd Pfizer shot. Joint pain has increased, but possibly from suspension of MTX and coincident decrease in prednisone dosage. Restarted wkly MTX 4 days ago.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-10
-
2022-02-17
Survey response — day 35, dose 3MedDRA: Asthenia, Pre-existing disease, Rheumatoid arthritis — Feeling: FairFree text: RA symptoms increasing; energy decreasing.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-24
- 2022-04-14
- 2022-07-14
-
2022-12-22
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-12-22
- 2022-12-23
- 2022-12-24
- 2022-12-25
- 2022-12-26
- 2022-12-27
- 2022-12-28
- 2022-12-29
- 2023-01-05
- 2023-01-12
-
2023-02-01
Survey response — day 35, dose 4MedDRA: Brain fog, Pre-existing disease, Vitreous detachment, Vitreous floaters — Feeling: GoodMedDRA releases: 2024-11
- 2023-03-23
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
| 4 | 2022-12-22 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 successful
Free text
Release 9 — 3 months, dose 2
Release 9 — 6 months, dose 2
Symptoms: Systemic inflammation, especially joints, eyes, lips
Healthcare visit (other): PCP and specialists in-office
Release 11 — day 21, dose 3
Symptoms: Having rheumatoid arthritis (RA) , I had stopped methotrexate (MTX) for 2 weeks after getting 3rd Pfizer shot. Joint pain has increased, but possibly from suspension of MTX and coincident decrease in prednisone dosage. Restarted wkly MTX 4 days ago. cut off by CDC
Release 11 — day 35, dose 3
Symptoms: RA symptoms increasing; energy decreasing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cheilitis | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Eye inflammation | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rheumatoid arthritis | · | · | ✓ |
| SD | Vitreous detachment | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release